US Patent Issued to Pacira Therapeutics on Aug. 25 for "Effective dosages of an adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis in humans, and compositions comprising the same" (Austrian, American Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,755, issued on Aug. 25, was assigned to Pacira Therapeutics Inc. (Brisbane, Calif.).

"Effective dosages of an adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis in humans, and compositions comprising the same" was invented by Scott Kelley (Burlington, Mass.), Rebecca Senter (Boston), Monika Chabicovsky (Vienna), Emily Walsh Martin (Boston), Neil Bodick (Boston), Won Hong (Burlington, Mass.), Kris Wang (Burlington, Mass.), Mark Douglas (Burlington, Mass.) and John Derek Jackson (Burlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to pharmaceutical compositions and ...